Found "AI": 1,093 results
Navigating the Landscape of Digital Health: Australia
Executive Summary
Australia has a history of innovation, which is reflected in the breadth of health technologies that are increasingly available in the country’s digital health landscape. This breadth of digital health technologies can be categorised across four domains: Software as a Medical De
Navigating the Landscape of Digital Health: South Korea
Executive Summary
Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan
Concept Note: HTA guideline Project (A stepwise guide for HTA guideline development)
The focus of HTA in this project is HTA for benefit package design. The main output will be a step-by-step guide for HTA methods and/or process guideline development, starting from key considerations in the initial phase to support the set-up of a conducive environment for good HTA, steps to follow
Concept note: Rapid assessment of road traffic injuries related policies and their economic impact in Sri Lanka
Road traffic accidents (RTAs) represent an increasing human and socio-economic problem worldwide and have been identified as one of the target areas under the Sustainable Development Goals (SDGs) to “halve the number of global deaths and injuries from road traffic accidents” (SDG 3.6). In Sri Lanka,
Research Proposal: Economic evaluation, budget impact analysis, and feasibility of using PET-CT scan in staging and response assessment of patients with diffuse large B-cell lymphoma (DLBCL)
มะเร็งต่อมน้ำเหลืองชนิดนอนฮอดจ์กิน (non-Hodgkin’s Lymphoma; NHL) เป็น 1 ใน 10 ของมะเร็งที่พบบ่อยในคนไทย และเป็น 1 ใน 10 ของมะเร็งที่เป็นสาเหตุของการเสียชีวิตในคนไทย โดยในระยะเวลา 5 ปี พบผู้ป่วยโรคมะเร็งต่อมน้ำเหลืองชนิด NHL จำนวนกว่า 19,000 ราย โดยมีอัตราอุบัติการณ์ปรับอายุ (age-standardized inciden
What is the value of a Quality-Adjusted Life Year and How Much Is It ?
The value of a Quality-Adjusted Life Year (QALY) used to screen medicines for inclusion in the National List of Essential Medicines (NLEM) in 2013 was 160,000 baht per QALY. Any medicines that cost less than this amount is considered to be cost-effective. However, is this figure consistent with publ
Health Technology Assessment for Renal Dialysis for End-Stage Renal Disease in Indonesia
Due to the increasing burden of non-communicable diseases (NCDs) in aging populations and the prevalence of unhealthy lifestyles, end-stage renal disease (ESRD) that results from NCDs is a growing concern in Indonesia. With the target of achieving Universal Health Coverage (UHC) by 2019, public prov
Health Technology Assessment on Sildenafil as Treatment for Pulmonary Arterial Hypertension (PAH)
Sildenafil is a treatment option for PAH patients that is found to offer an additional 1-3 life years gained for PAH patients compared to beraprost, currently the only treatment available in the benefit package under the National Social Health Insurance (Jaminan Kasehatan Nasional – JKN) of Indonesi
The Quality and Outcomes Framework Project: Incentive to develop primary care quality
Primary care services are health services which are the first point of contact in the healthcare system and play a role in the health of the local population. The Quality and Outcomes Framework (QOF) project, which is managed by the Ministry of Public Health (MoPH) and National Health Security Offic
Off-label medicines: Rational or Irrational?
The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries
and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems.
It is therefore important to have a rational an
10 / Page